• (PLX AI) – Genmab is impressive but the stock is priced for perfection, SEB analysts said, reiterating their sell recommendation on the stock.
  • • Price target raised to DKK 2,430 from DKK 2,220
  • • Genmab was down 1.2% in morning trading in Copenhagen

Quelle: PLX AI